269 related articles for article (PubMed ID: 2615924)
41. P300 and genetic risk for schizophrenia.
Winterer G; Egan MF; Raedler T; Sanchez C; Jones DW; Coppola R; Weinberger DR
Arch Gen Psychiatry; 2003 Nov; 60(11):1158-67. PubMed ID: 14609891
[TBL] [Abstract][Full Text] [Related]
42. [Negative schizophrenic symptomatology and the P 300 potential].
Drouet A; Hort-Legrand C; Féline A; Métral S
Encephale; 1993; 19(3):229-35. PubMed ID: 8275908
[TBL] [Abstract][Full Text] [Related]
43. Information processing during eye tracking as revealed by event-related potentials in schizophrenics, alcoholics, and healthy controls.
Kathmann N; Wagner M; Rendtorff N; Schöchlin C; Engel RR
Schizophr Res; 1995 Aug; 16(2):145-56. PubMed ID: 7577768
[TBL] [Abstract][Full Text] [Related]
44. P300 responses to novel auditory stimuli in hospitalized schizophrenic patients.
Merrin EL; Floyd TC
Biol Psychiatry; 1994 Oct; 36(8):527-42. PubMed ID: 7827216
[TBL] [Abstract][Full Text] [Related]
45. Relationship between exploratory eye movement, P300, and reaction time in schizophrenia.
Takahashi S; Tanabe E; Sakai T; Matsuura M; Matsushima E; Obayashi S; Kojima T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):396-403. PubMed ID: 18778436
[TBL] [Abstract][Full Text] [Related]
46. P300 in patients with unilateral temporal lobectomies: the effects of reduced stimulus quality.
Scheffers MK; Johnson R; Ruchkin DS
Psychophysiology; 1991 May; 28(3):274-84. PubMed ID: 1946893
[TBL] [Abstract][Full Text] [Related]
47. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
Coburn KL; Shillcutt SD; Tucker KA; Estes KM; Brin FB; Merai P; Moore NC
Biol Psychiatry; 1998 Sep; 44(6):466-74. PubMed ID: 9777178
[TBL] [Abstract][Full Text] [Related]
48. P300 and smooth eye pursuit: concordance of abnormalities and relation to clinical features in DSM-III schizophrenia.
Ebmeier KP; Potter DD; Cochrane RH; Mackenzie AR; MacAllister H; Besson JA; Salzen EA
Acta Psychiatr Scand; 1990 Oct; 82(4):283-8. PubMed ID: 2260480
[TBL] [Abstract][Full Text] [Related]
49. P300 reduction and prolongation with illness duration in schizophrenia.
Mathalon DH; Ford JM; Rosenbloom M; Pfefferbaum A
Biol Psychiatry; 2000 Mar; 47(5):413-27. PubMed ID: 10704953
[TBL] [Abstract][Full Text] [Related]
50. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
Mori K; Morita K; Shoji Y; Matsuoka T; Fujiki R; Uchimura N
Psychiatry Clin Neurosci; 2012 Jun; 66(4):261-9. PubMed ID: 22624730
[TBL] [Abstract][Full Text] [Related]
51. P300 amplitude over temporal regions in schizophrenia.
Iwanami A; Kato N; Kasai K; Kamio S; Furukawa S; Fukuda M; Nakagome K; Araki T; Okajima Y; Isono H; Kamijima K
Eur Arch Psychiatry Clin Neurosci; 2002 Feb; 252(1):1-7. PubMed ID: 12056575
[TBL] [Abstract][Full Text] [Related]
52. Long-term physical exercise and somatosensory event-related potentials.
Iwadate M; Mori A; Ashizuka T; Takayose M; Ozawa T
Exp Brain Res; 2005 Jan; 160(4):528-32. PubMed ID: 15586274
[TBL] [Abstract][Full Text] [Related]
53. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
[No Abstract] [Full Text] [Related]
54. Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia.
Pinkham AE; Liu P; Lu H; Kriegsman M; Simpson C; Tamminga C
Am J Psychiatry; 2015 Aug; 172(8):784-92. PubMed ID: 25815418
[TBL] [Abstract][Full Text] [Related]
55. Hemispheric preference of paranoid and nonparanoid schizophrenics.
Magaro PA; Chamrad DL
Biol Psychiatry; 1983 Nov; 18(11):1269-85. PubMed ID: 6652163
[TBL] [Abstract][Full Text] [Related]
56. Phenylthiocarbamide (PTC) tasting in paranoid and nonparanoid schizophrenic patients.
Schlosberg A; Baruch I
Percept Mot Skills; 1992 Apr; 74(2):383-6. PubMed ID: 1594398
[TBL] [Abstract][Full Text] [Related]
57. Event-related potentials during rule processing in schizophrenia.
Posada A; Zalla T; Vianin P; Georgieff N; Franck N
Psychiatry Res; 2005 Mar; 134(1):55-66. PubMed ID: 15808290
[TBL] [Abstract][Full Text] [Related]
58. Effect of age and global function score on schizophrenic p300 characteristics.
Yu YW; Chen TJ; Chen MC; Tsai SJ; Lee TW
Neuropsychobiology; 2005; 51(1):45-52. PubMed ID: 15627813
[TBL] [Abstract][Full Text] [Related]
59. Decreased P300 current source density in drug-naive first episode schizophrenics revealed by high density recording.
Wang J; Tang Y; Li C; Mecklinger A; Xiao Z; Zhang M; Hirayasu Y; Hokama H; Li H
Int J Psychophysiol; 2010 Mar; 75(3):249-57. PubMed ID: 20004691
[TBL] [Abstract][Full Text] [Related]
60. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings.
de Wilde OM; Bour LJ; Dingemans PM; Koelman JH; Boerée T; Linszen DH
Clin Neurophysiol; 2008 Dec; 119(12):2721-6. PubMed ID: 18986832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
